Valuation: Acotec Scientific Holdings Limited

Market Cap 156.24Cr 183.18Cr 23Cr 21Cr 19Cr 18Cr 33Cr 2.21TCr 34Cr 232.62Cr 91Cr 1.15TCr 88Cr 86Cr 3.69TCr P/E 2026 *
11.6x
P/E 2027 * 9.23x
Enterprise Value 156.24Cr 183.18Cr 23Cr 21Cr 19Cr 18Cr 33Cr 2.21TCr 34Cr 232.62Cr 91Cr 1.15TCr 88Cr 86Cr 3.69TCr EV / Sales 2026 *
2.15x
EV / Sales 2027 * 1.72x
Free-Float
16.41%
Yield 2026 *
-
Yield 2027 * -
1 day+0.86%
1 week-1.59%
Current month-6.58%
1 month-2.72%
3 months-28.98%
6 months-49.40%
Current year-56.33%
1 week 5.74
Extreme 5.735
6.05
1 month 5.5
Extreme 5.5
6.32
Current year 5.5
Extreme 5.5
15.32
1 year 5.5
Extreme 5.5
15.32
3 years 5.26
Extreme 5.26
15.47
5 years 4.21
Extreme 4.21
19.88
10 years 4.21
Extreme 4.21
19.88
Manager TitleAgeSince
Chief Executive Officer 54 29/01/2021
Chief Tech/Sci/R&D Officer 48 29/01/2021
Chief Tech/Sci/R&D Officer 85 29/01/2021
Director TitleAgeSince
Chairman 54 29/01/2021
Director/Board Member 56 03/12/2020
Director/Board Member 79 29/01/2021
Date Insider Type Main position Quantity % Market Cap. Importance
13/07/26 Other

Chief Executive Officer

-6,28,316 0.2005%
08/06/23 Other

Chief Executive Officer

72,08,000 2.3000%
24/09/21 Other

Chief Executive Officer

3,42,000 0.1091%
Change 5-day change 1-year change 3-year change Capi.($)
+0.86%-1.59%-53.91%-53.95% 23Cr
+2.29%+6.28%-19.13%+15.20% 18TCr
+1.29%+8.77%+0.12%+32.64% 12TCr
+4.12%+5.87%-20.70%+13.71% 11TCr
+0.41%+3.99%-44.97%-9.38% 7.57TCr
+1.56%+6.24%+6.82%+80.66% 6.42TCr
+1.98%+1.58%+15.03%+67.32% 5.35TCr
+2.58%+6.02%+3.74%-25.10% 5.15TCr
+3.43%+6.63%-14.39%+28.39% 4.17TCr
+1.78%+2.32% - - 3.15TCr
Average +2.03%+4.71%-14.15%+16.61% 7.25TCr
Weighted average by Cap. +2.18%+5.81%-11.84%+23.17%

Financials

2026 *2027 *
Net sales 73Cr 85Cr 11Cr 9.71Cr 9.02Cr 8.21Cr 15Cr 1.03TCr 16Cr 108.39Cr 42Cr 537.5Cr 41Cr 40Cr 1.72TCr 91Cr 106.69Cr 14Cr 12Cr 11Cr 10Cr 19Cr 1.29TCr 20Cr 135.49Cr 53Cr 671.88Cr 51Cr 50Cr 2.15TCr
Net income 13Cr 15Cr 1.91Cr 1.71Cr 1.59Cr 1.44Cr 2.72Cr 181.13Cr 2.76Cr 19Cr 7.46Cr 95Cr 7.18Cr 7.02Cr 302.41Cr 16Cr 19Cr 2.45Cr 2.19Cr 2.03Cr 1.85Cr 3.48Cr 232.07Cr 3.54Cr 24Cr 9.55Cr 121.09Cr 9.2Cr 9Cr 387.47Cr
Net Debt - -
Projected Income Statement - Annual - Acotec Scientific Holdings Limited
Logo Acotec Scientific Holdings Limited
Acotec Scientific Holdings Ltd is a company engaged in interventional medical device business. The Company is primarily engaged in the research and development on providing treatment solutions for vascular diseases, involving drug-coated balloons (DCB) and percutaneous transluminal angioplasty balloon catheters (PTA). The Company’s main products include AcoArt Orchid & Dhalia, AcoArt Tulip & Litos, AcoArt Iris & Jasmin, AcoArt Lily & Rosmarin, Peripheral Aspiration System (AcoStream), Radiofrequency Ablation System (AcoArt Cedar), 2nd Gen Peripheral Aspiration System (2nd Generation AcoStream) and others, covering fields such as vascular surgery, cardiology, nephrology and neurology. The Company conducts its businesses within domestic and overseas markets.
Employees
955
Date Price Change Volume
16/26/16 HK$5.895 +0.86% 1,24,000
15/26/15 HK$5.845 +1.12% 4,78,000
14/26/14 HK$5.780 -1.87% 5,80,000
13/26/13 HK$5.890 +0.17% 5,65,000
12/26/12 HK$5.880 -1.84% 4,71,000
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Acotec Scientific Holdings Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.986CNY
Average target price
15.00CNY
Spread / Average Target
+200.81%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Acotec Scientific Holdings Limited
  1. Stock Market
  2. Stocks
  3. 6669 Stock